Magnesium hydroxide


Generic Medicine Info
Administration
Susp: Should be taken on an empty stomach. Take 1 hr after meals & at bedtime.
Contraindications
Acute gastrointestinal conditions; severe renal failure.
Special Precautions
Patients with myasthenia gravis or neuromuscular disease, sudden change in bowel habits (which persists for >2 weeks), Mg-restricted diet; stomach pain, nausea or vomiting. Debilitated patients. Renal and hepatic impairment. Children and elderly. Pregnancy and lactation.
Adverse Reactions
Significant: Rarely, hypermagnesaemia (particularly in patients with renal impairment). Gastrointestinal disorders: Abdominal pain, diarrhoea (dose-dependent), colic.
Drug Interactions
May decrease absorption of certain antibiotics (e.g. cefpodoxime, tetracyclines, quinolones), antifungals (e.g. itraconazole), antivirals (e.g. atazanavir, rilpivirine), fexofenadine, bisphosphonates (e.g. alendronic acid, ibandronic acid), corticosteroids (e.g. dexamethasone, deflazacort), antiepileptics (e.g. gabapentin, phenytoin), certain antipsychotics (e.g. sulpiride, chlorpromazine), ACE inhibitors (e.g. captopril), rosuvastatin, chloroquine, hydroxychloroquine, proguanil, digoxin, dipyridamole, levothyroxine, mycophenolate, iron preparations, nilotinib, and penicillamine. May increase absorption of ibuprofen. May decrease the excretion of quinidine. May enhance the adverse or toxic effect, particularly metabolic alkalosis, of sodium polystyrene sulfonate. Excretion of salicylates may be increased.
CIMS Class
Antacids, Antireflux Agents & Antiulcerants / Laxatives, Purgatives
ATC Classification
G04BX01 - magnesium hydroxide ; Belongs to the class of other urologicals.
A02AA04 - magnesium hydroxide ; Belongs to the class of magnesium-containing antacids.
Disclaimer: This information is independently developed by CIMS based on magnesium hydroxide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in